Literature DB >> 7688835

Immunolocalization of fibroblast growth factor receptor 1 and its ligands in human tissues.

S E Hughes1, P A Hall.   

Abstract

BACKGROUND: The fibroblast growth factors (FGFs) and their receptors have a wide range of biologic actions in a variety of systems. The best characterized are the prototypical acidic and basic FGFs, both of which have the property of binding to the flg gene product, fibroblast growth factor receptor-1/FGFR-1. Although much is known at the molecular level, the available information about the in vivo distribution of FGFs and their receptors in human tissues is limited. Detailed characterization of the spatial distribution of ligands and receptors is a necessary prerequisite for understanding their function. EXPERIMENTAL
DESIGN: Using immunohistochemical techniques, we have defined the tissue specific cellular location of both FGFR-1 and basic and acidic FGFs in serial sections of a broad range of normal human adult tissues. Immunodetection was performed using highly specific polyclonal antibodies to FGFR-1, acidic FGF, and basic FGF and the avidin-biotin immunoperoxidase method.
RESULTS: Immunoreactive acidic and basic FGFs were present in almost all tissues examined. A distinct spatial pattern of distribution of these ligands was observed in the kidney, skin, liver, ureter, and the vasculature. FGFR-1 expression tended to be confined to the tissue microvasculature. Interestingly, marked numbers of FGFR-1 reactive vessels were observed in the stomach, salivary glands, lung, and appendix. Intense FGFR-1 positivity was observed in the basal epithelial cell layer of the cervix, palatine tonsil, and respiratory tract as well as breast myoepithelial cells, and the pitutary gland.
CONCLUSIONS: We have been able to define the distribution of FGFR-1 and its ligands in normal human tissues. The results will be useful for determining the function of these growth factors and their receptors under both normal physiologic and pathologic conditions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688835

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  20 in total

1.  A sensory neuron subpopulation with unique sequential survival dependence on nerve growth factor and basic fibroblast growth factor during development.

Authors:  C G Acosta; A R Fábrega; D H Mascó; H S López
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

2.  Expression of acidic fibroblast growth factor (aFGF) and fibroblast growth factor receptor 4 (FGFR4) in breast fibroadenomas.

Authors:  S La Rosa; F Sessa; L Colombo; M G Tibiletti; D Furlan; C Capella
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

3.  Fibroblast growth factor 10 alters the balance between goblet and Paneth cells in the adult mouse small intestine.

Authors:  Denise Al Alam; Soula Danopoulos; Kathy Schall; Frederic G Sala; Dana Almohazey; G Esteban Fernandez; Senta Georgia; Mark R Frey; Henri R Ford; Tracy Grikscheit; Saverio Bellusci
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-02-26       Impact factor: 4.052

4.  Transduction of well-differentiated airway epithelium by recombinant adeno-associated virus is limited by vector entry.

Authors:  R Bals; W Xiao; N Sang; D J Weiner; R L Meegalla; J M Wilson
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

5.  Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy.

Authors:  J Floege; W Kriz; M Schulze; M Susani; D Kerjaschki; A Mooney; W G Couser; K M Koch
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

6.  Expression of basic fibroblast growth factor in intact and ulcerated human gastric mucosa.

Authors:  M A Hull; J L Brough; D G Powe; G I Carter; D Jenkins; C J Hawkey
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

7.  Fibroblast growth factor receptor-1 expression is associated with neointimal formation in vitro.

Authors:  S J Daley; A I Gotlieb
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

8.  Expression of fibroblast growth factor-1 and fibroblast growth factor-2 in normal liver and hepatocellular carcinoma.

Authors:  N H Chow; K S Cheng; P W Lin; S H Chan; W C Su; Y N Sun; X Z Lin
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

9.  Thyroid follicular oncogenesis in iodine-deficient and iodine-sufficient areas: search for alterations of the ras, met and bFGF oncogenes and of the Rb anti-oncogene.

Authors:  L Bartolone; F Vermiglio; M D Finocchiaro; M A Violi; D French; A Pontecorvi; F Trimarchi; S Benvenga
Journal:  J Endocrinol Invest       Date:  1998-11       Impact factor: 4.256

10.  Expression of fibroblast growth factor receptor genes in human hepatoma-derived cell lines.

Authors:  Nobuyuki Asada; Yoshiharu Tanaka; Yasutaka Hayashido; Shigeaki Toratani; Mikio Kan; Mikiya Kitamoto; Toshio Nakanishi; Goro Kajiyama; Kazuaki Chayama; Tetsuji Okamoto
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Jul-Aug       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.